How has Abbott's R&D spending changed since 2022?

Abbott Laboratories' Research and Development (R&D) spending has demonstrated a consistent upward trend over the past two years, with a few fluctuations. Here's a detailed analysis:

1. Growth Trend: Abbott's R&D expenses have increased from $2.89 billion in 2022 to $2.84 billion in 2023, and then to $2.74 billion in 2024. This indicates a general upward trajectory in the company's investment in research and development.
2. Yearly Variations: There are slight variations in the R&D spending within the same year. For instance, there was a decrease from $2.89 billion in 2022 to $2.74 billion in 2023, which was then followed by a decrease from $2.74 billion in 2023 to $2.84 billion in 2024.
3. Stability: Despite these fluctuations, the overall trend shows a stable increase in R&D spending. This suggests that Abbott is committed to investing in innovation and is likely to continue supporting its growth through research and development.